A drug called roscovitine, which acts as a partial corrector of the F508del CFTR protein [61] and recruits TRPC6 to phagosomal membranes of alveolar MΦ, is able to restore the microbicidal function compromised by CF [62]. Here, CFTR is linked to cystic fibrosis.